Microbiology of Meropenem-Vaborbactam: A Novel Carbapenem Beta-Lactamase Inhibitor Combination for Carbapenem-Resistant Enterobacterales Infections
Author:
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical)
Link
https://link.springer.com/content/pdf/10.1007/s40121-020-00350-1.pdf
Reference37 articles.
1. Lai CC, Chen CC, Tang HJ. Meropenem-vaborbactam in the treatment of acute bacterial infections. J Clin Med. 2019;8(10):1650.
2. Drawz SM, Papp-Wallace KM, Bonomo RA. New beta-lactamase inhibitors: a therapeutic renaissance in an MDR world. Antimicrob Agents Chemother. 2014;58(4):1835–46.
3. Letourneau A. Combination beta-lactamase inhibitors, carbapenems, and monobactams. In: Hooper D, Bloom A (Ed.) UpToDate, Waltham, MA. 2020.
4. Adam D. Beta-lactam/beta-lactamase inhibitor combinations in empiric management of pediatric infections. J Int Med Res. 2002;30(Suppl 1):10A–A1919.
5. Finegold S. In vitro efficacy of betalactam/beta-lactamase inhibitor combinations against bacteria involved in mixed infections. Int J Antimicrob Agents. 1999;12:S9–S14.
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Meropenem/Vaborbactam—A Mechanistic Review for Insight into Future Development of Combinational Therapies;Antibiotics;2024-05-21
2. Activity of aztreonam-avibactam against Enterobacterales resistant to recently approved beta-lactamase inhibitor combinations collected in Europe, Latin America, and the Asia-Pacific Region (2020–2022);International Journal of Antimicrobial Agents;2024-04
3. Antimicrobials: An update on new strategies to diversify treatment for bacterial infections;Advances in Microbial Physiology;2024
4. Antibiotic resistance and a dire need for novel and innovative therapies: The impending crisis;Syncytia;2023-12-31
5. Approaches to Testing Novel β-Lactam and β-Lactam Combination Agents in the Clinical Laboratory;Antibiotics;2023-12-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3